These findings highlight the critical role of obesity-related inflammation in enhancing the aggressiveness of luminal breast cancer, suggesting that this environment may influence the expression of ESR2 as well as oxidative stress and mitochondrial biomarkers. The gene discussed is ESR2; the disease is obesity due to melanocortin 4 receptor deficiency.